Abstract:Introduction Voxel based morphometry (VBM) is a neuroimaging analysis technique that allows investigation of focal differences in brain anatomy, using the statistical approach of so-called statistical parametric mapping [1,2]. Major depressive disorder (MDD) is a common and serious psychiatric illness. In past study, the authors have done many researches to reveal the change in grey matter [3-7]. However, the neurobiology of MDD is largely unknown. The purpose of the present study was to identify brain regions with gray matter volume and density changes with relative large MDD subjects and controls using optimized voxel-based morphometry. Material and Method Fifty one patients experiencing MDD (mean age = 34.6 ± 12.7, twenty five males and twenty eight females) according to the diagnostic criterion of DSM-IV, who had a score of 18 or greater on the 17-item Hamilton Depression Rating Scale (HAMD), and fifty two age and sex matched normal controls (mean age = 37.2 ± 16.1, twenty three males and twenty eight females) were recruited. MR scanning was carried out on a 3.0 TMR scanner (EXCITE, GE Signa, Milwaukee, USA). High resolution 3-dimensional T1-weighted (T1W) images were acquired employing a spoiled gradient recalled (SPGR) sequence with TR/TE = 8.5/3.4 ms, FA = 120, 156 axial slices with thickness = 1 mm, axial FOV 24 × 24 cm and data matrix = 256 × 256. Optimized voxel-based morphometry [2] was conducted using Statistical Parametric Mapping–2 (SPM2) (Welcome Department of Imaging Neuroscience, London [http://www.fil.ion.ucl.ac.uk/spm]). The voxel-based morphometry–2 toolbox, which implements the optimized voxel-based morphometry approach [2], was used for data preprocessing. Voxel-by-voxel-based comparisons of gray matter density and volume were performed between groups using two-sample t tests. The correlation between the regional gray matter changes and clinical symptom severity was examined. A corrected p value of less than 0.001 was deemed to be significant. Results Patients with MDD exhibited higher grey matter volume than normal controls in multiple brain regions including bilateral thalamus, left and right superior parietal lobule, right frontal lobe (Table 1, Figure 1 A, B and C). MDD patients also showed higher grey matter density than normal controls in bilateral thalamus (cluster level p < 0.001, corrected) (Table 1, Figure 1 D). No significant correlation between regional gray matter changes and HAMD scores was found after controlling for age, years of education and duration of illness.

A Voxel-Based Meta-Analysis Comparing Medication-Naive Patients of Major Depression with Treated Longer-Term Ill Cases.

Alterations of Brainstem Volume in Patients with First-Episode and Recurrent Major Depressive Disorder

Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study.

Essential brain structural alterations in major depressive disorder: A voxel-wise meta-analysis on first episode, medication-naive patients.

Brain Grey Matter Abnormalities in Medication-Free Patients with Major Depressive Disorder: a Meta-Analysis

Meta‐Analysis of Brain Volumetric Abnormalities in Patients with Remitted Major Depressive Disorder

Gray matter volume abnormalities were associated with sustained attention in unmedicated major depression.

Voxelwise Meta-Analysis of Gray Matter Reduction in Major Depressive Disorder

Brain Grey Matter Volume Alterations Associated with Antidepressant Response in Major Depressive Disorder.

Longitudinal brain volume changes in major depressive disorder

Voxel-based morphometric analysis on the volume of gray matter in bipolar I disorder.

Volumetric Deficit Within the Fronto-Limbic-Striatal Circuit in First-Episode Drug Naïve Patients With Major Depression Disorder

A Joint Study of Whole Exome Sequencing and Structural MRI Analysis in Major Depressive Disorder.

Connectome Analysis of Functional and Structural Hemispheric Brain Networks in Major Depressive Disorder

Molecular, Functional, and Structural Imaging of Major Depressive Disorder

Structural Neuroimaging and Molecular Signatures of Drug‐Naive Depression With Melancholic Features

The difference in volumetric alternations of the orbitofrontal-limbic-striatal system between major depressive disorder and anxiety disorders: A systematic review and voxel-based meta-analysis

Pharmacological treatment-associated brain structural and functional alterations in major depressive disorder: A narrative review

Brain Volume Abnormalities in Major Depressive Disorder: a Meta-analysis of Magnetic Resonance Imaging Studies

Regional gray matter changes in major depressive disorder : an optimized voxel-based morphometry study

Gray matter abnormalities in patients with major depressive disorder and social anxiety disorder: a voxel-based meta-analysis